cemiplimab+fianlimab

DRUG2 trials

Sponsors

Grupo Español Multidisciplinar de Melanoma, University of Chicago

Conditions

Head and Neck CancerMelanoma BRAF V600E/K MutatedMelanoma and Brain Metastases

Phase 2

Encorafenib and biNimetinib Followed by CEmiplimab and FiAnLimab in Patients With BRAF Mutant melanOma and Symptomatic Brain Metastases

RecruitingNCT06887088

Grupo Español Multidisciplinar de MelanomaMelanoma and Brain Metastases, Melanoma BRAF V600E/K Mutated

Start: 2025-05-29End: 2028-01-31Target: 33Updated: 2025-10-01

A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Treatment

Not yet recruitingNCT07179315

University of ChicagoHead and Neck Cancer

Start: 2026-12-01End: 2029-11-30Target: 68Updated: 2026-03-04